FDA
Ertugliflozin
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- ERTUGLIFLOZIN 5MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERTUGLIFLOZIN 5MG · TabletThis page
- ERTUGLIFLOZIN 15MG · TabletANDA216842-002 · Discontinued
- ERTUGLIFLOZIN 5MG · TabletANDA216947-001 · Discontinued
- ERTUGLIFLOZIN 15MG · TabletANDA216947-002 · Discontinued
- ERTUGLIFLOZIN 5MG · TabletANDA217071-001 · Discontinued
- ERTUGLIFLOZIN 15MG · TabletANDA217071-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA216842.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ertugliflozin
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hikma
- Status
- Discontinued
- FDA approval
- 21 Jan 2025
- Application
- ANDA216842-001